Quantum BioPharma (NASDAQ:QNTM), a biopharmaceutical company focused on treatments for neurodegenerative disorders, has acquired 2,000 shares of GameStop (NYSE:GME) as a strategic investment to be held on its balance sheet.
“The Quantum team and I see the extreme value in GameStop going forward and the deep value the company has with 90% cash and marketable securities on their balance sheet,” said Kevin Malone, Board Advisor to Quantum BioPharma.
